Aethlon Medical Stock (NASDAQ:AEMD)

Ownership Financials Chart Transcripts

Previous Close

$1.33

52W Range

$1.10 - $8.48

50D Avg

$1.97

200D Avg

$3.35

Market Cap

$3.31M

Avg Vol (3M)

$248.75K

Beta

1.69

Div Yield

AEMD Company Profile

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

IPO Date

Mar 04, 1999

Website

AEMD Performance

AEMD Financial Summary

	Mar 25	Mar 24	Mar 23
Revenue	-	-	$574.25K
Operating Income	-	$-12.64M	$-11.90M
Net Income	$-13.39B	$-12.21M	$-12.03M
EBITDA	-	$-11.85M	$-11.66M
Basic EPS	$-8.58	$-4.86	$-5.86
Diluted EPS	$-8.58	$-4.86	$-5.90

Fiscal year ends in Mar 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 25Jun 26, 25 | 4:30 PM

Q3 25Feb 12, 25 | 4:30 PM

Q2 25Nov 13, 24 | 4:30 PM

Peer Comparison

Ticker	Company
GOVX	GeoVax Labs, Inc.
APDN	Applied DNA Sciences, Inc.
BBLG	Bone Biologics Corporation
CTSO	Cytosorbents Corporation
TIVC	Tivic Health Systems, Inc.